A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

ZHUHAI, GUANGDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- Environmental responsibility has transitioned from ...

As a showcase of youth innovation, future artificial intelligence technology took center stage in Rancho Cordova with ...

As AI accelerates, leaders must fundamentally reimagine their digital operating model, harnessing AI as a catalyst to ...

Modine Manufacturing Company ( MOD) Discusses Spin-Off and Combination of Performance Technologies Segment with Gentherm January 29, 2026 9:15 AM EST ...

YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced it ...

Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.

Over the past decade, circulating tumor DNA (ctDNA) has emerged as one of the most transformative biomarkers in oncology, offering unprecedented ...

Google unveils AI that can predict how DNA mutations cause disease - ‘This could add another piece of the puzzle for the discovery of drug targets and ultimately, the development of new drugs,’ says ...

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

The RFI outlines a broad and technically ambitious vision for how Special Operations Forces collect, analyze, and exploit identity-related data during missions.

Crime scene DNA test results in minutes rather than weeks or months. It’s a new technology now in the hands of investigators at the King County Sheriff’s Office. It’s called the Rapid DNA machine. “It ...